wuxi pharmatech

Gene sequencing company raises $200m

With the debate about gene-edited babies raging, it is a sensitive time for Wuxi NextCODE to announce the completion of Series C funding.

November 29, 2018

Wuxi AppTec joins biologics IPO rush

Chinese biopharmaceutical firm to list biologics arm in Hong Kong after delisting in New York in 2015. All the signs are it will deliver healthy returns for backers of its privatisation.

May 25, 2017

Wuxi Biologics readies Hong Kong relisting

Wuxi PharmaTech is looking to relist its biologic arm in Hong Kong after the group was taken private through a management buyout in late 2015.

January 06, 2017

Wuxi PharmaTech closing in on $3.3b take-private

The deal would be the second-largest privatisation of a US-listed Chinese company and could pave the way for a relisting in China or Hong Kong if completed.

November 12, 2015

WuXi raises $185 million from IPO

The NYSE listing of the Chinese drug research company receives substantial demand, enabling it to price 8% higher than the top of the range.

August 09, 2007